Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. XRAY
stocks logo

XRAY

-
Add to WatchlistAdvanced Chart
$
0.000
0(0.000%)1D
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
929.67M
-5.52%
0.495
+1.12%
902.93M
-5.05%
0.458
-8.37%
934.33M
+3.24%
0.506
+94.71%
Estimates Revision
The market is revising Upward the revenue expectations for DENTSPLY SIRONA Inc. (XRAY) for FY2025, with the revenue forecasts being adjusted by 1.91% over the past three months. During the same period, the stock price has changed by 22.31%.
Revenue Estimates for FY2025
Revise Upward
up Image
+1.91%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+2.4%
In Past 3 Month
Stock Price
Go Up
up Image
+22.31%
In Past 3 Month
12 Analyst Rating
up Image0
Wall Street analysts forecast XRAY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for XRAY is 17.75 USD with a low forecast of 14.00 USD and a high forecast of 25.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
9 Hold
0 Sell
Hold
up Image0
Current: 15.680
sliders
Low
14.00
Averages
17.75
High
25.00
up Image0
Current: 15.680
sliders
Low
14.00
Averages
17.75
High
25.00
Leerink
Market Perform
maintain
$17
2025-07-14
New
Reason
Leerink
Price Target
$17
2025-07-14
New
maintain
Market Perform
Reason
Leerink raised the firm's price target on Dentsply Sirona to $17 from $16.50 and keeps a Market Perform rating on the shares. Heading into Q2 earnings, the firm is updating dental company estimates and publishing the results of its fourth semi-annual dental survey of 63 dental practitioners in the United States. There is clearly a budding interest in identifying incremental improvements across the dental space, even if each opportunity seems to be company-specific in what remains a still-challenged total dental end-market, Leerink says. The firm sees reasons to be positive on each stock in its coverage but also has some offsetting questions that limit too much constructiveness.
Barrington
Michael Petusky
Outperform
maintain
$20 -> $21
2025-05-12
Reason
Barrington
Michael Petusky
Price Target
$20 -> $21
2025-05-12
maintain
Outperform
Reason
UBS
Buy
downgrade
$27 -> $25
2025-05-09
Reason
UBS
Price Target
$27 -> $25
2025-05-09
downgrade
Buy
Reason
UBS lowered the firm's price target on Dentsply Sirona to $25 from $27 and keeps a Buy rating on the shares.
Evercore ISI
In Line
maintain
$15 -> $17
2025-05-08
Reason
Evercore ISI
Price Target
$15 -> $17
2025-05-08
maintain
In Line
Reason
Mizuho
Neutral
downgrade
$18 -> $16
2025-04-24
Reason
Mizuho
Price Target
$18 -> $16
2025-04-24
downgrade
Neutral
Reason
Mizuho lowered the firm's price target on Dentsply Sirona to $16 from $18 and keeps a Neutral rating on the shares. The firm believes many companies in the dental sector "may post less-than-stellar growth" in Q1. The recent American Dental Association Q1 survey results further reinforce a cautious view, so Mizuho trimmed Q1 estimates for broad dental manufacturers, the analyst tells investors in a research note.
Needham
David Saxon
Strong Buy
to
Hold
Downgrades
n/a
2025-03-13
Reason
Needham
David Saxon
Price Target
n/a
2025-03-13
Downgrades
Strong Buy
to
Hold
Reason
Needham analyst David Saxon downgraded Dentsply Sirona to Hold from Buy without a price target. With a debate around whether the dental market's long-term growth profile has shifted lower and recent indicators pointing to weakening U.S. consumer sentiment, Needham does not expect dental market growth to improve in the near-term, the analyst tells investors in a research note. The firm says that with Dentsply and ZimVie both seeing below-market growth and no meaningful upside catalyst to drive near-term multiple expansion, it no longer believes the stocks can outperform relative to its broader coverage.
See All Ratings

Valuation Metrics

The current forward P/E ratio for DENTSPLY SIRONA Inc (XRAY.O) is 8.20, compared to its 5-year average forward P/E of 17.19. For a more detailed relative valuation and DCF analysis to assess DENTSPLY SIRONA Inc 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PE
17.19
Current PE
8.20
Overvalued PE
21.94
Undervalued PE
12.43

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
12.56
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
15.25
Undervalued EV/EBITDA
9.88

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
2.08
Current PS
0.00
Overvalued PS
2.82
Undervalued PS
1.34

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

XRAY News & Events

Events Timeline

(ET)
2025-05-08
06:08:30
Dentsply Sirona backs FY25 adjusted EPS view $1.80-$2.00, consensus $1.80
select
2025-05-08
06:06:55
Dentsply Sirona reports Q1 adjusted EPS 43c, consensus 30c
select
2025-03-17 (ET)
2025-03-17
08:48:44
Dentsply Sirona appoints David Ferguson as SVP, global business unit leader
select
Sign Up For More Events
Sign Up For More Events

News

Preview
8.0
06-25NASDAQ.COM
Ex-Dividend Reminder: REV Group, Medtronic and DENTSPLY SIRONA

  • Upcoming Ex-Dividend Dates: REV Group Inc, Medtronic PLC, and DENTSPLY SIRONA Inc will trade ex-dividend on June 27, 2025, with respective dividends of $0.06, $0.71, and $0.16 payable on July 11, 2025.

  • Market Impact and Historical Yields: Following the ex-dividend date, shares are expected to open lower by approximately 0.13% for REV Group, 0.82% for Medtronic, and 1.02% for DENTSPLY. Current estimated annual yields are 0.54%, 3.30%, and 4.09% respectively for these companies.

Preview
5.0
06-25NASDAQ.COM
DENTSPLY SIRONA Named Top Dividend Stock With Insider Buying and 4.13% Yield (XRAY)

  • Insider Buying Insight: The article highlights DENTSPLY SIRONA Inc (XRAY) as a notable company where insider buying occurred, specifically by Director Gregory T. Lucier, who purchased shares at $16.51 each, indicating confidence in the company's value and potential growth.

  • Dividend Performance and Valuation: The DividendRank report emphasizes XRAY's attractive valuation metrics, strong profitability, and a solid dividend history, making it an appealing option for dividend investors seeking profitable companies trading at favorable prices.

Preview
6.5
06-18Benzinga
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

  • Dividend-Yielding Stocks: Investors are increasingly turning to high dividend-yielding stocks during market uncertainty, particularly in the health care sector, with notable companies like Pfizer, Merck, and DENTSPLY SIRONA receiving various analyst ratings.

  • Investment Opportunities: Several platforms offer low minimum investments in real estate and alternative assets, allowing both accredited and non-accredited investors to earn passive income through dividends and appreciation.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is DENTSPLY SIRONA Inc (XRAY) stock price today?

The current price of XRAY is 15.68 USD — it has decreased -0.63 % in the last trading day.

arrow icon

What is DENTSPLY SIRONA Inc (XRAY)'s business?

DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. It develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices. Its Connected Technology Solutions segment includes design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of its value-added endodontic, restorative, and preventive consumable products and small equipment used by dental professionals for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and dental professional-directed aligner solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for urinary and bowel management.

arrow icon

What is the price predicton of XRAY Stock?

Wall Street analysts forecast XRAY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for XRAY is 17.75 USD with a low forecast of 14.00 USD and a high forecast of 25.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is DENTSPLY SIRONA Inc (XRAY)'s revenue for the last quarter?

DENTSPLY SIRONA Inc revenue for the last quarter amounts to 879.00M USD, decreased -7.76 % YoY.

arrow icon

What is DENTSPLY SIRONA Inc (XRAY)'s earnings per share (EPS) for the last quarter?

DENTSPLY SIRONA Inc. EPS for the last quarter amounts to 0.10 USD, increased 11.11 % YoY.

arrow icon

What changes have occurred in the market's expectations for DENTSPLY SIRONA Inc (XRAY)'s fundamentals?

The market is revising Upward the revenue expectations for DENTSPLY SIRONA Inc. (XRAY) for FY2025, with the revenue forecasts being adjusted by 1.91% over the past three months. During the same period, the stock price has changed by 22.31%.
arrow icon

How many employees does DENTSPLY SIRONA Inc (XRAY). have?

DENTSPLY SIRONA Inc (XRAY) has 14000 emplpoyees as of July 19 2025.

arrow icon

What is DENTSPLY SIRONA Inc (XRAY) market cap?

Today XRAY has the market capitalization of 3.12B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free